InvestorsObserver
×
News Home

Premarket Mover: Biondvax Pharmaceuticals Ltd - ADR (BVXV) Down 9.15%

Tuesday, June 06, 2023 06:50 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Biondvax Pharmaceuticals Ltd - ADR (BVXV) Down 9.15%

Biondvax Pharmaceuticals Ltd - ADR (BVXV) is lower by Tuesday morning, with the stock losing -9.15% in pre-market trading to 1.39. BVXV's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Biotechnology industry, which ranks 66 out of 146 industries, the stock ranks higher than 4% of stocks. Biondvax Pharmaceuticals Ltd - ADR has fallen 21.13% over the past month, closing at $1.94 on May 9. During this period of time, the stock fell as low as $1.70 and as high as $1.96. The company has an average price target of $8.00.

Overall Score - 2
BVXV has an Overall Score of 2. Find out what this means to you and get the rest of the rankings on BVXV!
Biondvax Pharmaceuticals Ltd - ADR has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 65 by this metric, BVXV ranks better than 65% of stocks.

Important Dates for Investors in BVXV:

-Biondvax Pharmaceuticals Ltd - ADR is set to release earnings on 8/13/2023 -We do not have a set dividend date for Biondvax Pharmaceuticals Ltd - ADR at this time. Click Here To Get The Full Report on Biondvax Pharmaceuticals Ltd - ADR (BVXV)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App